PACS
PACS Group, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+37/100
Last price
43.14
▲ 0.43 (1.01%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
43.35
Prev close
42.71
Day high
43.87
Day low
42.43
Volume
920.55K
Market cap
$6.78B
P/E (TTM)
25.04
52W range
10.31 – 49.49
Day trading desk
Gap from prior close
+1.49%
Prior close 42.71
VWAP
42.93
+0.48% from price
Relative volume
2.08×
Unusually busy
Session range
3.39%
42.43 – 43.87
Position in range
49%
Mid range
ATR (14D)
1.42
3.28% of price
Prior day high
43.29
PDH
Prior day low
42.39
PDL
Bid / ask spread
—
Quote not published
Session volume
1.67M
Avg 804.61K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.33%
-0.6%
1M
+0.73%
-0.4%
3M
-2.75%
-7.3%
6M
+31.93%
+13.7%
YTD
+11.51%
-2.7%
1Y
+212.71%
+196.3%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PACS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-1.67M
Net selling
Buy transactions
11
176.50K shares
Sell transactions
20
1.84M shares
Net transactions
+31
Buys less sells
Sell : buy shares
10.4 : 1
Heavily one-sided
Insider-held shares
109.44M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 5, 26 | MURRAY JASON HULSE Chief Executive Officer |
SELL | 83.31K | $3.50M | Direct |
| Sep 16, 26 | JERGENSEN JOSHUA President |
SELL | 40.00K | $1.73M | Direct |
| Sep 15, 26 | HANCOCK MARK Director and Beneficial Owner of more than 10% of a Class of Security |
SELL | 300.00K | $13.04M | Direct |
| Sep 14, 26 | MURRAY JASON HULSE Chief Executive Officer |
SELL | 19.62K | $886.57K | Direct |
| Sep 9, 26 | MURRAY JASON HULSE Chief Executive Officer |
SELL | 51.89K | $2.24M | Direct |
| Sep 3, 26 | MURRAY JASON HULSE Chief Executive Officer |
SELL | 68.11K | $2.90M | Direct |
| Aug 21, 26 | MURRAY JASON HULSE Chief Executive Officer |
SELL | 150.55K | $6.61M | Direct |
| Aug 19, 26 | MURRAY JASON HULSE Chief Executive Officer |
SELL | 236.12K | $10.44M | Direct |
| Aug 18, 26 | HANCOCK MARK Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 88.00K | $0 | Direct |
| Aug 14, 26 | CONWAY PATRICK HUGH Director |
SELL | 3.50K | $155.30K | Direct |
| Aug 12, 26 | JERGENSEN JOSHUA President |
SELL | 40.00K | $1.82M | Direct |
| Jul 15, 26 | JERGENSEN JOSHUA President |
SELL | 40.00K | $1.80M | Direct |
| Jul 15, 26 | HANCOCK MARK Director and Beneficial Owner of more than 10% of a Class of Security |
SELL | 13.63K | $613.79K | Direct |
| Jul 9, 26 | HANCOCK MARK Director and Beneficial Owner of more than 10% of a Class of Security |
SELL | 25.30K | $1.14M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BINGHAM TRENT DEAN |
Officer | 39.65K | Stock Award(Grant) |
DILSAVER EVELYN S |
Director | 36.09K | Stock Award(Grant) |
HANCOCK MARK |
Director and Beneficial Owner of more than 10% of a Class of Security | 53.52M | Sale |
HENDRICKSON CAREY P |
Chief Financial Officer | 48.43K | Stock Award(Grant) |
JERGENSEN JOSHUA |
President | 2.50M | Sale |
LEWIS MICHELLE RENEE |
Officer | 355.34K | Sale |
MILLARD JACQUELINE |
Director | 20.22K | Stock Award(Grant) |
MITCHELL JOHN TODD |
Officer | 803.57K | Sale |
MURRAY JASON HULSE |
Chief Executive Officer | 54.47M | Sale |
PRIEGNITZ KELLY |
Officer | 38.20K | Stock Award(Grant) |
Fundamentals
Market cap$6.78B
Enterprise value$10.02B
Revenue (TTM)$5.55B
Gross profit$961.21M
EBITDA$478.30M
Net income$269.17M
EPS (TTM)$1.71
Free cash flow$378.32M
Total cash$164.45M
Total debt$3.40B
Book value / share$7.01
Shares outstanding158.34M
Float48.84M
Short % of float7.74%
Dividend yield0.00%
Beta (5Y)-0.08
Valuation & profitability ratios
Trailing P/E25.04
Forward P/E15.77
PEG ratio1.08
Price / sales—
Price / book6.10
EV / revenue1.81
EV / EBITDA20.96
Gross margin17.32%
Operating margin7.66%
Profit margin4.85%
Return on equity27.92%
Return on assets4.60%
Debt / equity305.27
Current ratio0.91
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.29B | $4.09B | $3.11B | $2.42B | +29.3% |
| Operating revenue | $5.29B | $4.09B | $3.11B | $2.40B | +29.4% |
| Cost of revenue | $4.51B | $3.58B | $2.66B | $2.02B | +25.9% |
| Gross profit | $780.33M | $507.69M | $447.07M | $400.68M | +53.7% |
| Selling, general & admin | $415.07M | $343.81M | $213.66M | $149.01M | +20.7% |
| Total operating expense | $470.73M | $384.62M | $239.30M | $171.32M | +22.4% |
| Operating income | $309.60M | $123.07M | $207.77M | $229.36M | +151.6% |
| Net interest income | -$28.36M | -$44.34M | -$49.92M | -$25.54M | +36.0% |
| Pre-tax income | $284.45M | $101.55M | $157.32M | $207.04M | +180.1% |
| Tax provision | $92.99M | $46.21M | $44.44M | $56.55M | +101.2% |
| Net income | $191.54M | $55.76M | $112.87M | $150.50M | +243.5% |
| Net income to common | $191.54M | $55.76M | $112.87M | $150.50M | +243.5% |
| Basic EPS | 1.23 | 0.38 | 0.76 | 1.00 | +223.7% |
| Diluted EPS | 1.22 | 0.38 | 0.76 | 1.00 | +221.1% |
| EBIT | $312.81M | $145.90M | $207.24M | $232.58M | +114.4% |
| EBITDA | $368.48M | $186.70M | $232.87M | $254.89M | +97.4% |
| Basic shares | 156.18M | 146.66M | 147.77M | 150.15M | +6.5% |
| Diluted shares | 156.70M | 148.57M | 147.77M | 150.15M | +5.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $197.02M | $157.67M | $73.42M | $58.27M | +25.0% |
| Cash & short-term investments | $197.02M | $157.67M | $73.42M | $58.27M | +25.0% |
| Accounts receivable | $628.13M | $641.77M | $547.81M | $370.92M | -2.1% |
| Total current assets | $1.07B | $938.26M | $722.15M | $511.16M | +14.0% |
| Property, plant & equipment | $4.17B | $3.99B | $2.59B | $1.78B | +4.6% |
| Goodwill & intangibles | $68.06M | $67.06M | $65.29M | $61.49M | +1.5% |
| Total assets | $5.58B | $5.24B | $3.51B | $2.46B | +6.5% |
| Total current liabilities | $1.00B | $978.43M | $456.93M | $483.86M | +2.4% |
| Current debt | $4.46M | $156.85M | $16.82M | $61.36M | -97.2% |
| Long-term debt | $344.80M | $250.98M | $715.71M | $438.34M | +37.4% |
| Total debt | $3.47B | $3.50B | $2.80B | $1.93B | -0.9% |
| Total liabilities | $4.63B | $4.53B | $3.41B | $2.39B | +2.3% |
| Retained earnings | $309.58M | $118.04M | $96.00M | $63.52M | +162.3% |
| Shareholder equity | $946.77M | $709.55M | $96.13M | $63.65M | +33.4% |
| Working capital | $68.31M | -$40.17M | $265.22M | $27.30M | +270.0% |
| Net tangible assets | $878.71M | $642.49M | $30.84M | $2.15M | +36.8% |
| Shares issued | 156.62M | 155.18M | 147.77M | 147.77M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $191.46M | $55.34M | $112.88M | $150.50M | +245.9% |
| Depreciation & amortisation | $55.66M | $40.81M | $25.63M | $22.31M | +36.4% |
| Stock-based compensation | $54.07M | $115.54M | $0 | $0 | -53.2% |
| Change in working capital | $72.71M | $158.22M | -$94.66M | -$94.29M | -54.0% |
| Operating cash flow | $404.22M | $367.34M | $63.70M | $92.61M | +10.0% |
| Capital expenditure | -$249.16M | -$349.81M | -$172.81M | -$78.24M | +28.8% |
| Investing cash flow | -$264.02M | -$442.68M | -$172.79M | -$75.32M | +40.4% |
| Dividends paid | $0 | -$33.72M | -$80.39M | -$60.28M | +100.0% |
| Financing cash flow | -$68.99M | $117.48M | $129.59M | $12.35M | -158.7% |
| Free cash flow | $155.07M | $17.53M | -$109.11M | $14.38M | +784.5% |
| End cash position | $232.05M | $160.84M | $118.70M | $98.21M | +44.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.43B | $1.42B | $1.36B | $1.34B | $1.31B | — | +0.5% |
| Operating revenue | $1.43B | $1.42B | $1.36B | $1.34B | $1.31B | — | +0.5% |
| Cost of revenue | $1.18B | $1.17B | $1.13B | $1.14B | $1.12B | — | +1.2% |
| Gross profit | $243.76M | $250.43M | $223.56M | $203.20M | $194.01M | — | -2.7% |
| Selling, general & admin | $114.31M | $112.31M | $113.49M | $102.53M | $100.33M | — | +1.8% |
| Total operating expense | $134.43M | $130.39M | $128.87M | $116.93M | $113.51M | — | +3.1% |
| Operating income | $109.33M | $120.03M | $94.69M | $86.27M | $80.50M | — | -8.9% |
| Net interest income | -$6.04M | -$6.42M | -$8.58M | -$8.53M | -$4.35M | — | +5.9% |
| Pre-tax income | $105.84M | $113.74M | $86.81M | $76.30M | $78.61M | — | -6.9% |
| Tax provision | $29.49M | $33.07M | $27.03M | $23.97M | $27.65M | — | -10.8% |
| Net income | $76.37M | $80.69M | $59.70M | $52.41M | $50.96M | — | -5.4% |
| Net income to common | $76.37M | $80.69M | $59.70M | $52.41M | $50.96M | — | -5.4% |
| Basic EPS | 0.48 | 0.51 | — | 0.33 | 0.33 | 0.18 | -5.9% |
| Diluted EPS | 0.47 | 0.50 | — | 0.32 | 0.31 | 0.17 | -6.0% |
| EBIT | $111.88M | $120.16M | $95.39M | $84.83M | $82.97M | — | -6.9% |
| EBITDA | $132.00M | $138.24M | $110.77M | $99.23M | $96.14M | — | -4.5% |
| Basic shares | 158.11M | 157.07M | — | 156.58M | 156.34M | 155.18M | +0.7% |
| Diluted shares | 161.99M | 162.08M | — | 164.71M | 165.47M | 166.42M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $164.45M | $247.98M | $197.02M | $355.67M | $294.17M | -33.7% |
| Cash & short-term investments | $164.45M | $247.98M | $197.02M | $355.67M | $294.17M | -33.7% |
| Accounts receivable | $634.50M | $648.04M | $628.13M | $628.28M | $638.13M | -2.1% |
| Total current assets | $962.35M | $1.07B | $1.07B | $1.13B | $1.08B | -9.9% |
| Property, plant & equipment | $4.26B | $4.22B | $4.17B | $4.13B | $4.07B | +1.0% |
| Goodwill & intangibles | $68.06M | $68.06M | $68.06M | $68.06M | $67.06M | 0.0% |
| Total assets | $5.66B | $5.66B | $5.58B | $5.63B | $5.50B | -0.1% |
| Total current liabilities | $1.06B | $1.07B | $1.00B | $1.20B | $1.17B | -1.7% |
| Current debt | $7.38M | $8.38M | $4.46M | $107.47M | $152.15M | -12.0% |
| Long-term debt | $238.71M | $284.81M | $344.80M | $245.90M | $246.99M | -16.2% |
| Total debt | $3.25B | $3.37B | $3.47B | $3.47B | $3.54B | -3.4% |
| Total liabilities | $4.54B | $4.62B | $4.63B | $4.75B | $4.69B | -1.7% |
| Retained earnings | $466.64M | $390.27M | $309.58M | $249.88M | $197.47M | +19.6% |
| Shareholder equity | $1.11B | $1.04B | $946.77M | $871.32M | $806.84M | +7.1% |
| Working capital | -$92.70M | -$5.42M | $68.31M | -$70.87M | -$90.01M | -1,611.0% |
| Net tangible assets | $1.04B | $969.11M | $878.71M | $803.26M | $739.78M | +7.6% |
| Shares issued | 158.34M | 157.17M | 156.62M | 156.62M | 156.57M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $76.35M | $80.67M | $59.78M | $52.33M | $50.97M | — | -5.4% |
| Depreciation & amortisation | $20.12M | $18.08M | $15.38M | $14.40M | $13.18M | — | +11.3% |
| Stock-based compensation | $25.83M | $20.35M | $15.75M | $12.52M | $13.60M | — | +27.0% |
| Change in working capital | $27.11M | $118.14M | -$119.82M | $127.91M | -$39.78M | — | -77.1% |
| Operating cash flow | $135.51M | $236.34M | -$3.39M | $204.80M | $52.57M | — | -42.7% |
| Capital expenditure | -$130.81M | -$108.35M | -$114.26M | -$98.36M | -$18.82M | — | -20.7% |
| Investing cash flow | -$155.74M | -$126.96M | -$118.15M | -$97.06M | -$32.41M | — | -22.7% |
| Dividends paid | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$76.57M | -$67.71M | -$5.47M | -$46.32M | -$13.13M | — | -13.1% |
| Free cash flow | $4.70M | $127.99M | -$117.65M | $106.44M | $33.76M | — | -96.3% |
| End cash position | $176.91M | $273.71M | $232.05M | $359.06M | $297.64M | — | -35.4% |
Options analytics
Put / call volume
7.50
Put-heavy session
Put / call open interest
1.15
Positioning, not flow
Max pain
40.00
-6.6% from spot
ATM implied vol
59.7%
Nearest strike to spot
Skew (10% OTM)
-7.0%
Calls bid over puts
Call volume
4
Contracts, this expiry
Put volume
30
Contracts, this expiry
Heaviest call OI
40.00
117 contracts
Heaviest put OI
40.00
178 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.56 | 0.63 | +11.7% |
| Mar 2026 | 0.41 | 0.64 | +56.8% |
| Dec 2025 | 0.46 | 0.57 | +25.7% |
| Sep 2025 | 0.47 | 0.45 | -3.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.60 | 4 | $1.46B | +8.4% |
| Next quarter | 0.62 | 4 | $1.52B | +12.2% |
| Current year | 2.52 | 4 | $5.83B | +10.2% |
| Next year | 2.71 | 4 | $6.39B | +9.6% |
Analyst targets & ownership
Mean target$59.00
High target$62.00
Low target$57.00
Implied upside36.76%
Analyst count6
ConsensusNONE
Strong buy / Buy2 / 4
Hold0
Sell / Strong sell0 / 0
Held by insiders69.12%
Held by institutions31.64%
Institutions holding341
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
42.01
+2.70% from price
SMA 20
42.57
+0.56% from price
SMA 50
43.86
-2.38% from price
SMA 100
41.98
+2.75% from price
SMA 200
39.05
+9.62% from price
EMA 12
42.32
+1.95% from price
EMA 26
42.67
+1.09% from price
EMA 50
42.82
+0.74% from price
RSI (14)
50.7
Neutral
MACD (12,26,9)
-0.36
Hist 0.15
ATR (14)
1.42
3.31% of price
Realised vol 30D
31.6%
Annualised
Bollinger upper
44.99
20, 2σ
Bollinger lower
40.16
20, 2σ
50 / 200 cross
Golden
43.86 vs 39.05
Trend bias
Above 200
+9.62%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
31.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.9%
Peak to trough
Max drawdown 5Y
-82.0%
Peak to trough
ATR 14
1.42
3.31% of price
Beta (reported)
-0.08
5Y monthly, from filing
Short interest
Shares short
3.74M
Prior 3.58M
Change vs prior
+4.4%
Shorts adding
% of float
7.74%
Normal
% of shares out
2.36%
Against total outstanding
Days to cover
5.7
Crowded exit
Float
48.84M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 10, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 6, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 8, 26 | UBS | MAINTAINED | Buy | Buy |
| May 18, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 13, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Mar 4, 26 | UBS | MAINTAINED | Buy | Buy |
| Mar 4, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Feb 27, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Nov 20, 25 | RBC Capital | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-21
Periodic Financial Reports
10-Q · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-06-15
Corporate Changes & Voting Matters
8-K · 2026-05-11
Proxy Statements
DEFA14A · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-04-27
Corporate Changes & Voting Matters
8-K · 2026-03-05
Periodic Financial Reports
10-K · 2026-02-27
Headlines
PACS Group Insider Sold Shares Worth $3,499,286, According to a Recent SEC Filing
MT Newswires · 18h ago
Omega to Transition Operations of 32 Facilities in Florida to PACS Group
Business Wire · 2d ago
Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
Business Wire · 6d ago
PACS Names Patrick Murphy Chief Legal Officer Following John Mitchell's Retirement
MT Newswires · 15d ago
PACS Group Announces Chief Legal Officer Transition
Business Wire · 15d ago
PACS Group Insider Sold Shares Worth $1,725,133, According to a Recent SEC Filing
MT Newswires · 19d ago
PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026
Business Wire · 23d ago
Pacs Group Insider Sold Shares Worth $2,237,373, According to a Recent SEC Filing
MT Newswires · 27d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.